JMIR Cancer

metrics 2024

Fostering collaboration for a cancer-free future.

Introduction

JMIR Cancer is a premier open access journal published by JMIR Publications, Inc., dedicated to advancing the field of cancer research and oncology. Since its inception in 2015, the journal has become an invaluable resource for researchers, clinicians, and students alike, providing a platform for the dissemination of cutting-edge research and clinical insights. Operating out of Canada, JMIR Cancer holds noteworthy rankings, including a Q3 position in Cancer Research and Q2 in Oncology as of 2023, highlighting its significant contribution to the scientific community. With the journal's open access model, articles are made freely available, ensuring that vital research reaches a wide audience and fosters collaboration across disciplines. By focusing on innovative research, translational studies, and clinical practices related to cancer, JMIR Cancer aims to be at the forefront of knowledge translation and tumor biology, bridging the gap between laboratory findings and patient care.

Metrics 2024

SCIMAGO Journal Rank0.79
Journal Impact Factor3.30
Journal Impact Factor (5 years)3.10
H-Index24
Journal IF Without Self3.30
Eigen Factor0.00
Normal Eigen Factor0.38
Influence0.98
Immediacy Index0.30
Cited Half Life2.80
Citing Half Life5.60
JCI0.66
Total Documents323
WOS Total Citations789
SCIMAGO Total Citations1699
SCIMAGO SELF Citations86
Scopus Journal Rank0.79
Cites / Document (2 Years)3.26
Cites / Document (3 Years)3.30
Cites / Document (4 Years)3.41

Metrics History

Rank 2024

Scopus

Oncology in Medicine
Rank #200/404
Percentile 50.50
Quartile Q2
Cancer Research in Biochemistry, Genetics and Molecular Biology
Rank #148/230
Percentile 35.65
Quartile Q3

IF (Web Of Science)

ONCOLOGY
Rank 118/322
Percentile 63.50
Quartile Q2

JCI (Web Of Science)

ONCOLOGY
Rank 161/322
Percentile 50.00
Quartile Q3

Quartile History

Similar Journals

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Connecting Research and Practice in the Fight Against Cancer.
Publisher: SPRINGERISSN: 0171-5216Frequency: 12 issues/year

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, published by Springer, is a prestigious peer-reviewed journal dedicated to advancing the fields of cancer research and clinical oncology. With an impact factor reflecting its significance within the academic community, the journal operates under a rigorous quality standard and offers a wealth of knowledge spanning from 1979 and continuing through 2025. With its comprehensive scope, it encompasses a wide array of topics including novel therapeutic strategies, clinical trials, and cutting-edge research methodologies, making it an essential resource for researchers, practitioners, and students alike. The journal’s category quartiles highlight its competitive edge, ranking Q2 in Cancer Research and Q1 in Medicine (miscellaneous) as of 2023. This positioning underscores its role at the forefront of oncology discourse. Through this journal, contributors and readers alike engage with impactful research that informs clinical practices and enhances patient care in oncology. Access to the journal’s content, although not open access, ensures curated and high-quality insights available to the academic and professional community.

MEDICAL ONCOLOGY

Empowering oncology through groundbreaking insights.
Publisher: HUMANA PRESS INCISSN: 1357-0560Frequency: 1 issue/year

Medical Oncology, published by Humana Press Inc, stands as a significant contributor to the field of oncology, with its long-standing commitment to disseminating research and clinical findings relevant to the treatment and management of cancer. Established in 1994 and continuing through 2024, this journal publishes insightful articles that reflect the latest advancements in cancer research, hematology, and related medical fields. With an evolving impact factor and remarkable categorizations, including Q3 in Cancer Research and Q2 in both Hematology and Oncology, Medical Oncology serves as a pivotal resource for healthcare providers, researchers, and students dedicated to improving cancer outcomes. Although it does not offer open access, the journal is widely recognized for its rigorous peer-review process and high-quality publications, making it an essential platform for sharing innovative research and critical reviews in oncology.

JCO Oncology Practice

Transforming Oncology Through Evidence and Innovation
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2688-1527Frequency: 6 issues/year

JCO Oncology Practice is a premier peer-reviewed journal published by Lippincott Williams & Wilkins, specializing in the intersection of oncology and health policy. Established as a vital resource since 2020, this journal serves as a platform for the dissemination of innovative research, policy analysis, and clinical practice advancements aimed at enhancing cancer care. With its impressive impact factor and recognition in the top quartile (Q1) across multiple categories including Health Policy and Oncology, JCO Oncology Practice ranks #3 in Oncology Nursing and consistently shares cutting-edge insights that drive improvements within the field. The journal is accessible to a broad audience through its open access options, ensuring that vital knowledge reaches practitioners, researchers, and students alike. By prioritizing the latest evidence-based practices and addressing contemporary challenges in cancer treatment, JCO Oncology Practice plays an essential role in shaping the future of oncology practice and policy in the United States and beyond.

JMIR Research Protocols

Championing transparency in the evolution of medical practices.
Publisher: JMIR PUBLICATIONS, INCISSN: 1929-0748Frequency: 1 issue/year

JMIR Research Protocols, published by JMIR PUBLICATIONS, INC, is a leading open-access journal that has been at the forefront of advancing research methodologies since its inception in 2012. With its ISSN 1929-0748, this journal is dedicated to providing a platform for the publication of innovative study protocols in the field of medicine, ensuring rigorous peer review and promoting transparency in research practices. Based in Canada, the journal has steadily gained recognition, currently holding a prominent position in the Q3 category of Medicine (Miscellaneous), with an impressive Scopus rank of #211 out of 636, placing it in the 66th percentile of its field. Researchers and professionals will find that JMIR Research Protocols not only supports the open sharing of knowledge but also enhances collaboration among the scientific community. Its open-access policy ensures broader dissemination of research findings, making it an essential resource for anyone interested in the evolving landscape of medical research methodologies.

JCO Clinical Cancer Informatics

Connecting researchers and practitioners for a cancer-free future.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2473-4276Frequency: 1 issue/year

Welcome to JCO Clinical Cancer Informatics, an esteemed journal at the forefront of the intersection between oncology and health informatics. Published by Lippincott Williams & Wilkins, this journal is dedicated to advancing the understanding and application of cancer data through innovative informatics solutions. Since its inception in 2017, JCO Clinical Cancer Informatics has established itself as a critical resource for researchers, practitioners, and students, as evidenced by its high rankings in the 2023 Scimago Quartiles—Q2 in Cancer Research and Q1 in both Health Informatics and Oncology. With a commitment to open access, this journal aims to disseminate groundbreaking research findings that enhance cancer care and inform public health strategies. Positioned in the United States, it serves as a pivotal platform for sharing knowledge and fostering collaboration within the global cancer research community.

Journal of Cancer Survivorship

Empowering Cancer Survivors Through Research
Publisher: SPRINGERISSN: 1932-2259Frequency: 4 issues/year

The Journal of Cancer Survivorship, published by SPRINGER, serves as a premier platform for research dedicated to the complex realities faced by cancer survivors. Established in 2007, this esteemed journal focuses on the multifaceted aspects of oncology care, particularly within the nursing domain, reflecting its significance with a 2023 Q1 ranking in both Oncology and Oncology (nursing) categories. Additionally, it boasts impressive Scopus rankings, positioning it in the top tier of nursing and oncology fields. Targeted towards researchers, healthcare professionals, and students, the journal emphasizes advancements in survivorship care, psychosocial support, and health-related quality of life post-cancer treatment. With no open access option, the journal maintains a high standard of scholarly communications while ensuring rigorous peer review processes, making it an indispensable resource in the evolving landscape of cancer survivorship studies.

Digital Health

Unlocking the Future of Health with Digital Insights.
Publisher: SAGE PUBLICATIONS LTDISSN: 2055-2076Frequency: 1 issue/year

Digital Health is a pioneering open-access journal published by SAGE Publications Ltd, dedicated to advancing the field of health technology and its intersection with health policy, informatics, and the broader medical landscape. Since its inception in 2015, the journal has rapidly established itself as an essential resource for researchers, professionals, and students, serving as a platform for innovative research that leverages digital tools to improve health outcomes. Currently ranked in the Q2 category across four relevant domains, including Computer Science Applications and Health Informatics, it commands respect within the academic community. With its accessible framework, Digital Health facilitates the dissemination of critical findings and new methodologies that inform policy and practice. The journal’s commitment to open access promotes worldwide access and cooperation, making significant contributions to the evolving landscape of digital health.

Healthcare Informatics Research

Advancing healthcare through innovative informatics solutions.
Publisher: KOREAN SOC MEDICAL INFORMATICSISSN: 2093-3681Frequency: 4 issues/year

Healthcare Informatics Research, published by the Korean Society of Medical Informatics, is a leading open access journal that has been advancing the field of healthcare informatics since its inception in 2010. With an ISSN of 2093-3681 and E-ISSN of 2093-369X, the journal provides a vital platform for disseminating high-quality research aimed at improving healthcare systems through innovative informatics solutions. Recognized for its contributions, it holds a Q2 rank in Biomedical Engineering and Q3 rankings in both Health Informatics and Health Information Management for 2023, reflecting its stature within the academic community. The journal is committed to open access, ensuring that research is freely accessible to researchers, professionals, and students worldwide, thus promoting knowledge sharing and collaboration. Located in the dynamic city of Seoul, South Korea, the journal serves as a hub for groundbreaking studies that impact health systems globally, making it an essential resource for those at the forefront of healthcare technology and management.

South Asian Journal of Cancer

Empowering voices in oncology and cancer care.
Publisher: GEORG THIEME VERLAG KGISSN: 2278-330XFrequency: 4 issues/year

South Asian Journal of Cancer, published by GEORG THIEME VERLAG KG, is a pivotal platform for research in the fields of oncology and cancer research. Established in 2012 and operating under an Open Access model, this journal aims to disseminate high-quality, peer-reviewed articles that address crucial developments in cancer treatment, prevention, and research, particularly within the South Asian context. Despite its young history, the journal has been positioned within the Q4 quartile for both Cancer Research and Oncology, and while current Scopus rankings indicate it resides in the lower percentiles, its commitment to amplifying regional voices and research is invaluable. With its headquarters in Stuttgart, Germany, and a global readership, South Asian Journal of Cancer is dedicated to enhancing collaboration among researchers, healthcare professionals, and students, fostering a space for innovative ideas and advancements in cancer care as we progress through to 2024.

Cancer Management and Research

Pioneering new paths in cancer management and research.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1179-1322Frequency: 1 issue/year

Cancer Management and Research, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to advancing the field of oncology. Since its inception in 2009, this journal has established itself as a vital resource for researchers, clinicians, and healthcare professionals focused on cancer treatment and management. With its robust impact factor and impressive Scopus ranking in the 77th percentile of oncology medicine, it provides a prominent platform for sharing high-quality research. The journal covers a wide range of topics within cancer management, including innovative therapeutic strategies, clinical trials, patient care, and health policy, ensuring a comprehensive approach to current challenges in the field. Operating from New Zealand, it invites contributions that can shape the future of oncology and improve patient outcomes globally, making it an essential addition to the libraries of those engaged in cancer research and practice.